info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Valley Fever Companies

Valley fever, or coccidioidomycosis, is a fungal infection caused by the Coccidioides species of fungi. While there is no specific treatment for Valley fever in the form of pharmaceutical drugs or vaccines, several companies may be involved in research, diagnostic tools, and related areas.

Valley Fever Companies

 


Latest Valley Fever Companies Updates:


NIH awards $8 million grant to develop Valley Fever vaccine This December 2023 grant funding from the National Institutes of Health (NIH) supports the development of a potential Valley Fever vaccine by researchers at the University of Arizona.


New rapid diagnostic test shows promise for early detection A collaborative effort between researchers at UCSF and UC Berkeley has developed a promising new rapid diagnostic test for Valley Fever, potentially enabling quicker diagnosis and earlier treatment interventions.


Valley Fever Solutions secures $14 million Series A funding This venture capital funding will support the development and potential commercialization of Nikkomycin Z, a promising antifungal drug candidate for Valley Fever treatment.


Arizona biotech companies collaborate on Valley Fever research Several Arizona-based biotechnology companies are partnering with academic institutions and government agencies to develop new diagnostics, treatments, and preventative measures for Valley Fever.


List of Valley Fever Key companies in the market:



  • Novartis

  • Anacor Pharmaceuticals

  • Johnson and Johnson

  • Valeant Pharmaceutical

  • Bristol Meyer Squibb

  • GlaxoSmithKline Pharmaceuticals Limited

  • Galderma S.A.

  • Pfizer Inc.


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.